Jay M. Moyes, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 4,677 shares at $55.54 ($260K) on 2007-10-15, disclosed to the SEC on 2007-10-16.
Scheduled sale ($260k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.34 | 90 | $5K | 1.9% |
| 2 | $55.40 | 344 | $19K | 7.3% |
| 3 | $55.41 | 344 | $19K | 7.3% |
| 4 | $55.42 | 430 | $24K | 9.2% |
| 5 | $55.44 | 344 | $19K | 7.3% |
| 6 | $55.46 | 172 |
| $10K |
| 3.7% |
| 7 | $55.47 | 172 | $10K | 3.7% |
| 8 | $55.48 | 318 | $18K | 6.8% |
| 9 | $55.49 | 800 | $44K | 17.1% |
| 10 | $55.53 | 258 | $14K | 5.5% |
| 11 | $55.54 | 86 | $5K | 1.8% |
| 12 | $55.58 | 29 | $2K | 0.6% |
| 13 | $55.60 | 172 | $10K | 3.7% |
| 14 | $55.61 | 344 | $19K | 7.4% |
| 15 | $55.63 | 774 | $43K | 16.6% |
| Total | $55.50 avg | 4,677 | $260K | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |